BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23233602)

  • 21. Cutting edge genomics reveal new insights into tumour development, disease progression and therapeutic impacts in multiple myeloma.
    Dutta AK; Hewett DR; Fink JL; Grady JP; Zannettino ACW
    Br J Haematol; 2017 Jul; 178(2):196-208. PubMed ID: 28466550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
    Mandelli F; Petti MC; Lo Coco F
    Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Classification and genetic abnormalities of multiple myeloma].
    Hanamura I; Iida S
    Nihon Rinsho; 2015 Jan; 73(1):17-27. PubMed ID: 25626298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.
    Stewart AK; Bergsagel PL; Greipp PR; Dispenzieri A; Gertz MA; Hayman SR; Kumar S; Lacy MQ; Lust JA; Russell SJ; Witzig TE; Zeldenrust SR; Dingli D; Reeder CB; Roy V; Kyle RA; Rajkumar SV; Fonseca R
    Leukemia; 2007 Mar; 21(3):529-34. PubMed ID: 17230230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloma: classification and risk assessment.
    Fonseca R; Monge J
    Semin Oncol; 2013 Oct; 40(5):554-66. PubMed ID: 24135400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New developments and treatment in multiple myeloma: new insights on molecular biology.
    Drach J; Kaufmann H
    Ann Oncol; 2002; 13 Suppl 4():43-7. PubMed ID: 12401665
    [No Abstract]   [Full Text] [Related]  

  • 27. Many multiple myelomas: making more of the molecular mayhem.
    Chesi M; Bergsagel PL
    Hematology Am Soc Hematol Educ Program; 2011; 2011():344-53. PubMed ID: 22160056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent biological and therapeutic advances in multiple myeloma].
    Coppetelli U; Avvisati G; Tribalto M; Cantonetti M; La Verde G; Petrucci T; Stasi R; Papa G
    Recenti Prog Med; 1992 Sep; 83(9):520-7. PubMed ID: 1439122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics and molecular profiling of multiple myeloma: novel tools for clinical management?
    Tassone P; Tagliaferri P; Rossi M; Gaspari M; Terracciano R; Venuta S
    Eur J Cancer; 2006 Jul; 42(11):1530-8. PubMed ID: 16820292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of multiple myeloma.
    Higgins MJ; Fonseca R
    Best Pract Res Clin Haematol; 2005; 18(4):525-36. PubMed ID: 16026735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-Generation Sequencing Informing Therapeutic Decisions and Personalized Approaches.
    Szalat R; Munshi NC
    Am Soc Clin Oncol Educ Book; 2016; 35():e442-8. PubMed ID: 27249752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple myeloma: a model for scientific and clinical progress.
    San Miguel J
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):1-7. PubMed ID: 25696828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH.
    Cremer FW; Kartal M; Hose D; Bila J; Buck I; Bellos F; Raab MS; Brough M; Moebus A; Hager HD; Goldschmidt H; Moos M; Bartram CR; Jauch A
    Cancer Genet Cytogenet; 2005 Sep; 161(2):116-24. PubMed ID: 16102581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular profiling of multiple myeloma: from gene expression analysis to next-generation sequencing.
    Agnelli L; Tassone P; Neri A
    Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S55-68. PubMed ID: 23614397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic tools for risk-stratification in multiple myeloma].
    Braggio E; Albarracín Garramuño F
    Medicina (B Aires); 2013; 73(4):369-75. PubMed ID: 23924539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges.
    Pollack IF
    J Neurosurg Pediatr; 2011 Aug; 8(2):135-48. PubMed ID: 21806354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New approaches to treatment for multiple myeloma: durable remission and quality of life as primary goals.
    Durie BG
    Clin Lymphoma Myeloma; 2005 Nov; 6(3):181-90. PubMed ID: 16354323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New treatment and diagnostic test for multiple myeloma].
    Handa H
    Rinsho Byori; 2014 Apr; 62(4):337-51. PubMed ID: 25022063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the Way to New Horizons: Telemedicine in Oncology.
    Schlag PM
    Oncologist; 1997; 2(2):III-IV. PubMed ID: 10388041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.
    Laganà A; Perumal D; Melnekoff D; Readhead B; Kidd BA; Leshchenko V; Kuo PY; Keats J; DeRome M; Yesil J; Auclair D; Lonial S; Chari A; Cho HJ; Barlogie B; Jagannath S; Dudley JT; Parekh S
    Leukemia; 2018 Jan; 32(1):120-130. PubMed ID: 28642592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.